The global market for SNP Microarray Testing and Analysis was valued at US$ 1404 million in the year 2024 and is projected to reach a revised size of US$ 2486 million by 2031, growing at a CAGR of 8.5% during the forecast period.
SNP microarray testing and analysis is a powerful genetic technology that plays a crucial role in modern genetics research and clinical applications. It involves the use of microarray chips densely populated with thousands to millions of probes designed to detect single nucleotide polymorphisms (SNPs), which are the most common type of genetic variation in the human genome. By hybridizing a patient's or research subject's DNA sample to the microarray, the technology can rapidly identify and genotype these SNPs across a large portion of the genome. This data can be used for a wide range of purposes. In research, it enables genome - wide association studies (GWAS) to uncover genetic loci associated with complex diseases, traits, and drug responses. In clinical settings, SNP microarray testing can assist in diagnosing genetic disorders, detecting chromosomal abnormalities, and predicting an individual's susceptibility to certain diseases. Overall, SNP microarray testing and analysis provide a comprehensive and efficient way to explore the genetic basis of various biological phenomena and improve medical understanding and patient care.
North American market for SNP Microarray Testing and Analysis is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for SNP Microarray Testing and Analysis is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for SNP Microarray Testing and Analysis in Pharmaceuticals and Pharmacogenomics is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of SNP Microarray Testing and Analysis include Thermo Fisher Scientific, Illumina, Agilent, Roche, Bio-Rad, CD Genomics, Ambry Genetics, Labcorp, Allele Diagnostics, Sonic Genetics, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for SNP Microarray Testing and Analysis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding SNP Microarray Testing and Analysis.
The SNP Microarray Testing and Analysis market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global SNP Microarray Testing and Analysis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the SNP Microarray Testing and Analysis companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Illumina
Agilent
Roche
Bio-Rad
CD Genomics
Ambry Genetics
Labcorp
Allele Diagnostics
Sonic Genetics
Invitae
Genetics Generation Advancement (GGA)
Quest Diagnostics
CapitalBio
HNL Lab Medicine
Psomagen
VCGS
Genetics Associates
Segment by Type
Whole Genome SNP Microarray
Customized SNP Microarray
Segment by Application
Pharmaceuticals and Pharmacogenomics
Diagnostic Research
Agricultural Biotechnology
Breeding and Animal Livestock
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of SNP Microarray Testing and Analysis company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global SNP Microarray Testing and Analysis Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Whole Genome SNP Microarray
1.2.3 Customized SNP Microarray
1.3 Market by Application
1.3.1 Global SNP Microarray Testing and Analysis Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceuticals and Pharmacogenomics
1.3.3 Diagnostic Research
1.3.4 Agricultural Biotechnology
1.3.5 Breeding and Animal Livestock
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global SNP Microarray Testing and Analysis Market Perspective (2020-2031)
2.2 Global SNP Microarray Testing and Analysis Growth Trends by Region
2.2.1 Global SNP Microarray Testing and Analysis Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 SNP Microarray Testing and Analysis Historic Market Size by Region (2020-2025)
2.2.3 SNP Microarray Testing and Analysis Forecasted Market Size by Region (2026-2031)
2.3 SNP Microarray Testing and Analysis Market Dynamics
2.3.1 SNP Microarray Testing and Analysis Industry Trends
2.3.2 SNP Microarray Testing and Analysis Market Drivers
2.3.3 SNP Microarray Testing and Analysis Market Challenges
2.3.4 SNP Microarray Testing and Analysis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top SNP Microarray Testing and Analysis Players by Revenue
3.1.1 Global Top SNP Microarray Testing and Analysis Players by Revenue (2020-2025)
3.1.2 Global SNP Microarray Testing and Analysis Revenue Market Share by Players (2020-2025)
3.2 Global Top SNP Microarray Testing and Analysis Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by SNP Microarray Testing and Analysis Revenue
3.4 Global SNP Microarray Testing and Analysis Market Concentration Ratio
3.4.1 Global SNP Microarray Testing and Analysis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by SNP Microarray Testing and Analysis Revenue in 2024
3.5 Global Key Players of SNP Microarray Testing and Analysis Head office and Area Served
3.6 Global Key Players of SNP Microarray Testing and Analysis, Product and Application
3.7 Global Key Players of SNP Microarray Testing and Analysis, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 SNP Microarray Testing and Analysis Breakdown Data by Type
4.1 Global SNP Microarray Testing and Analysis Historic Market Size by Type (2020-2025)
4.2 Global SNP Microarray Testing and Analysis Forecasted Market Size by Type (2026-2031)
5 SNP Microarray Testing and Analysis Breakdown Data by Application
5.1 Global SNP Microarray Testing and Analysis Historic Market Size by Application (2020-2025)
5.2 Global SNP Microarray Testing and Analysis Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America SNP Microarray Testing and Analysis Market Size (2020-2031)
6.2 North America SNP Microarray Testing and Analysis Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America SNP Microarray Testing and Analysis Market Size by Country (2020-2025)
6.4 North America SNP Microarray Testing and Analysis Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe SNP Microarray Testing and Analysis Market Size (2020-2031)
7.2 Europe SNP Microarray Testing and Analysis Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe SNP Microarray Testing and Analysis Market Size by Country (2020-2025)
7.4 Europe SNP Microarray Testing and Analysis Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific SNP Microarray Testing and Analysis Market Size (2020-2031)
8.2 Asia-Pacific SNP Microarray Testing and Analysis Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific SNP Microarray Testing and Analysis Market Size by Region (2020-2025)
8.4 Asia-Pacific SNP Microarray Testing and Analysis Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America SNP Microarray Testing and Analysis Market Size (2020-2031)
9.2 Latin America SNP Microarray Testing and Analysis Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America SNP Microarray Testing and Analysis Market Size by Country (2020-2025)
9.4 Latin America SNP Microarray Testing and Analysis Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa SNP Microarray Testing and Analysis Market Size (2020-2031)
10.2 Middle East & Africa SNP Microarray Testing and Analysis Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa SNP Microarray Testing and Analysis Market Size by Country (2020-2025)
10.4 Middle East & Africa SNP Microarray Testing and Analysis Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific SNP Microarray Testing and Analysis Introduction
11.1.4 Thermo Fisher Scientific Revenue in SNP Microarray Testing and Analysis Business (2020-2025)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Illumina
11.2.1 Illumina Company Details
11.2.2 Illumina Business Overview
11.2.3 Illumina SNP Microarray Testing and Analysis Introduction
11.2.4 Illumina Revenue in SNP Microarray Testing and Analysis Business (2020-2025)
11.2.5 Illumina Recent Development
11.3 Agilent
11.3.1 Agilent Company Details
11.3.2 Agilent Business Overview
11.3.3 Agilent SNP Microarray Testing and Analysis Introduction
11.3.4 Agilent Revenue in SNP Microarray Testing and Analysis Business (2020-2025)
11.3.5 Agilent Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche SNP Microarray Testing and Analysis Introduction
11.4.4 Roche Revenue in SNP Microarray Testing and Analysis Business (2020-2025)
11.4.5 Roche Recent Development
11.5 Bio-Rad
11.5.1 Bio-Rad Company Details
11.5.2 Bio-Rad Business Overview
11.5.3 Bio-Rad SNP Microarray Testing and Analysis Introduction
11.5.4 Bio-Rad Revenue in SNP Microarray Testing and Analysis Business (2020-2025)
11.5.5 Bio-Rad Recent Development
11.6 CD Genomics
11.6.1 CD Genomics Company Details
11.6.2 CD Genomics Business Overview
11.6.3 CD Genomics SNP Microarray Testing and Analysis Introduction
11.6.4 CD Genomics Revenue in SNP Microarray Testing and Analysis Business (2020-2025)
11.6.5 CD Genomics Recent Development
11.7 Ambry Genetics
11.7.1 Ambry Genetics Company Details
11.7.2 Ambry Genetics Business Overview
11.7.3 Ambry Genetics SNP Microarray Testing and Analysis Introduction
11.7.4 Ambry Genetics Revenue in SNP Microarray Testing and Analysis Business (2020-2025)
11.7.5 Ambry Genetics Recent Development
11.8 Labcorp
11.8.1 Labcorp Company Details
11.8.2 Labcorp Business Overview
11.8.3 Labcorp SNP Microarray Testing and Analysis Introduction
11.8.4 Labcorp Revenue in SNP Microarray Testing and Analysis Business (2020-2025)
11.8.5 Labcorp Recent Development
11.9 Allele Diagnostics
11.9.1 Allele Diagnostics Company Details
11.9.2 Allele Diagnostics Business Overview
11.9.3 Allele Diagnostics SNP Microarray Testing and Analysis Introduction
11.9.4 Allele Diagnostics Revenue in SNP Microarray Testing and Analysis Business (2020-2025)
11.9.5 Allele Diagnostics Recent Development
11.10 Sonic Genetics
11.10.1 Sonic Genetics Company Details
11.10.2 Sonic Genetics Business Overview
11.10.3 Sonic Genetics SNP Microarray Testing and Analysis Introduction
11.10.4 Sonic Genetics Revenue in SNP Microarray Testing and Analysis Business (2020-2025)
11.10.5 Sonic Genetics Recent Development
11.11 Invitae
11.11.1 Invitae Company Details
11.11.2 Invitae Business Overview
11.11.3 Invitae SNP Microarray Testing and Analysis Introduction
11.11.4 Invitae Revenue in SNP Microarray Testing and Analysis Business (2020-2025)
11.11.5 Invitae Recent Development
11.12 Genetics Generation Advancement (GGA)
11.12.1 Genetics Generation Advancement (GGA) Company Details
11.12.2 Genetics Generation Advancement (GGA) Business Overview
11.12.3 Genetics Generation Advancement (GGA) SNP Microarray Testing and Analysis Introduction
11.12.4 Genetics Generation Advancement (GGA) Revenue in SNP Microarray Testing and Analysis Business (2020-2025)
11.12.5 Genetics Generation Advancement (GGA) Recent Development
11.13 Quest Diagnostics
11.13.1 Quest Diagnostics Company Details
11.13.2 Quest Diagnostics Business Overview
11.13.3 Quest Diagnostics SNP Microarray Testing and Analysis Introduction
11.13.4 Quest Diagnostics Revenue in SNP Microarray Testing and Analysis Business (2020-2025)
11.13.5 Quest Diagnostics Recent Development
11.14 CapitalBio
11.14.1 CapitalBio Company Details
11.14.2 CapitalBio Business Overview
11.14.3 CapitalBio SNP Microarray Testing and Analysis Introduction
11.14.4 CapitalBio Revenue in SNP Microarray Testing and Analysis Business (2020-2025)
11.14.5 CapitalBio Recent Development
11.15 HNL Lab Medicine
11.15.1 HNL Lab Medicine Company Details
11.15.2 HNL Lab Medicine Business Overview
11.15.3 HNL Lab Medicine SNP Microarray Testing and Analysis Introduction
11.15.4 HNL Lab Medicine Revenue in SNP Microarray Testing and Analysis Business (2020-2025)
11.15.5 HNL Lab Medicine Recent Development
11.16 Psomagen
11.16.1 Psomagen Company Details
11.16.2 Psomagen Business Overview
11.16.3 Psomagen SNP Microarray Testing and Analysis Introduction
11.16.4 Psomagen Revenue in SNP Microarray Testing and Analysis Business (2020-2025)
11.16.5 Psomagen Recent Development
11.17 VCGS
11.17.1 VCGS Company Details
11.17.2 VCGS Business Overview
11.17.3 VCGS SNP Microarray Testing and Analysis Introduction
11.17.4 VCGS Revenue in SNP Microarray Testing and Analysis Business (2020-2025)
11.17.5 VCGS Recent Development
11.18 Genetics Associates
11.18.1 Genetics Associates Company Details
11.18.2 Genetics Associates Business Overview
11.18.3 Genetics Associates SNP Microarray Testing and Analysis Introduction
11.18.4 Genetics Associates Revenue in SNP Microarray Testing and Analysis Business (2020-2025)
11.18.5 Genetics Associates Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
Thermo Fisher Scientific
Illumina
Agilent
Roche
Bio-Rad
CD Genomics
Ambry Genetics
Labcorp
Allele Diagnostics
Sonic Genetics
Invitae
Genetics Generation Advancement (GGA)
Quest Diagnostics
CapitalBio
HNL Lab Medicine
Psomagen
VCGS
Genetics Associates
听
听
*If Applicable.
